Meet with us at SSIEM!
Join us at SSIEM 2026, where the global inherited metabolic disease community comes together to share scientific advances, explore emerging therapies, and shape the future of rare disease research. Bringing together clinicians, researchers, industry leaders, and patient advocates, SSIEM highlights the latest developments in diagnosis, treatment, and clinical innovation for inherited metabolic disorders.
Connect with our team to learn more about:
- Rare disease and inherited metabolic disorder clinical development strategies
- Global clinical trial design and operational planning for complex studies
- Patient-centric approaches to recruitment, retention, and long-term follow-up
- Regulatory, clinical, and operational expertise to support development from early phase through commercialization
On-Site
- Angi Robinson, Sr. Vice President, Specialty Areas
- Ken Ndugga-Kabuye, Vice President, Cell and Gene Therapy
Fill out the form above to schedule a meeting with our on-site team.
Discover approaches to advancing inherited metabolic disorder and rare disease clinical research through strategic trial design, global operational expertise, and patient-centered execution.
